Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04507425 · ClinicalTrials.gov registry record · NA

High Flow Nasal Cannula With Noninvasive Ventilation

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT04507425 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04507425, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This is a prospective, randomized, unblinded trial of trauma patients in the ICU who are identified as being at a high risk to develop acute respiratory failure. We hope that this study will help the study team to identify how best to use a more aggressive respiratory treatment strategy in a high risk trauma population (thoracic trauma or trauma patients requiring thoracic surgery, spine surgery, or open abdominal procedures) to try and decrease the need for intubation with mechanical ventilation.

Interventions

  • OTHER Standard of Care - Nasal Cannula
  • OTHER High-flow nasal cannula
  • OTHER HFNC plus non-invasive ventilation

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-09-01
Est. Completion 2023-07-10
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT04507425

The ClinicalTrials.gov registry entry for NCT04507425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Standard of Care - Nasal Cannula is the first listed.

NCT04507425 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04507425 about?

NCT04507425 is a clinical study titled "High Flow Nasal Cannula With Noninvasive Ventilation". This is a prospective, randomized, unblinded trial of trauma patients in the ICU who are identified as being at a high risk to develop acute respiratory failure. We hope that this study will help the study team to identify how best to use a more aggressive respiratory treatment strategy in a high r...

What is the current status of trial NCT04507425?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-09-01. Estimated completion is 2023-07-10.

What interventions are being tested in trial NCT04507425?

The interventions under investigation include: Standard of Care - Nasal Cannula (OTHER), High-flow nasal cannula (OTHER), HFNC plus non-invasive ventilation (OTHER).

Who is sponsoring clinical trial NCT04507425?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.